Paris-based SquareMind, whose Swan robot uses AI for full-body dermoscopic skin imaging, raised $18M, including a previously undisclosed pre-Series A (Jim Hammerand/MassDevice)
SquareMind, a Paris-based AI-powered dermatology technology company, secured $18M in funding to advance its Swan robot for automated full-body skin imaging, representing a significant investment in AI-driven healthcare automation that could transform diagnostic workflows and reduce manual clinical labor. For IT organizations, this signals accelerating adoption of specialized AI robotics in healthcare settings, requiring healthcare CIOs to evaluate integration capabilities, data security frameworks for medical imaging, and interoperability with existing EHR systems. The business impact centers on potential cost reduction, improved diagnostic accuracy, and competitive differentiation for healthcare providers deploying such technologies.
Jim Hammerand / MassDevice: Paris-based SquareMind, whose Swan robot uses AI for full-body dermoscopic skin imaging, raised $18M, including a previously undisclosed pre-Series A — SquareMind has raised $18 million for its Swan robotic skin imaging platform, including an investment from Fred Moll's Sonder Capital.